Literature DB >> 22921946

Ammonium metabolism in humans.

Maria M Adeva1, Gema Souto, Natalia Blanco, Cristóbal Donapetry.   

Abstract

Free ammonium ions are produced and consumed during cell metabolism. Glutamine synthetase utilizes free ammonium ions to produce glutamine in the cytosol whereas glutaminase and glutamate dehydrogenase generate free ammonium ions in the mitochondria from glutamine and glutamate, respectively. Ammonia and bicarbonate are condensed in the liver mitochondria to yield carbamoylphosphate initiating the urea cycle, the major mechanism of ammonium removal in humans. Healthy kidney produces ammonium which may be released into the systemic circulation or excreted into the urine depending predominantly on acid-base status, so that metabolic acidosis increases urinary ammonium excretion while metabolic alkalosis induces the opposite effect. Brain and skeletal muscle neither remove nor produce ammonium in normal conditions, but they are able to seize ammonium during hyperammonemia, releasing glutamine. Ammonia in gas phase has been detected in exhaled breath and skin, denoting that these organs may participate in nitrogen elimination. Ammonium homeostasis is profoundly altered in liver failure resulting in hyperammonemia due to the deficient ammonium clearance by the diseased liver and to the development of portal collateral circulation that diverts portal blood with high ammonium content to the systemic blood stream. Although blood ammonium concentration is usually elevated in liver disease, a substantial role of ammonium causing hepatic encephalopathy has not been demonstrated in human clinical studies. Hyperammonemia is also produced in urea cycle disorders and other situations leading to either defective ammonium removal or overproduction of ammonium that overcomes liver clearance capacity. Most diseases resulting in hyperammonemia and cerebral edema are preceded by hyperventilation and respiratory alkalosis of unclear origin that may be caused by the intracellular acidosis occurring in these conditions.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22921946     DOI: 10.1016/j.metabol.2012.07.007

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  62 in total

1.  Discovery of 2,6-Dimethylpiperazines as Allosteric Inhibitors of CPS1.

Authors:  Alan Rolfe; Shihua Yao; Toung-Vi Nguyen; Kiyoyuki Omoto; Federico Colombo; Milena Virrankoski; Frédéric H Vaillancourt; Lihua Yu; Andrew Cook; Dominic Reynolds; Stephanos Ioannidis; Ping Zhu; Nicholas A Larsen; David M Bolduc
Journal:  ACS Med Chem Lett       Date:  2020-05-26       Impact factor: 4.345

2.  Aquaporin 4 as a NH3 Channel.

Authors:  Mette Assentoft; Shreyas Kaptan; Hans-Peter Schneider; Joachim W Deitmer; Bert L de Groot; Nanna MacAulay
Journal:  J Biol Chem       Date:  2016-07-19       Impact factor: 5.157

3.  Clinical utility of breath ammonia for evaluation of ammonia physiology in healthy and cirrhotic adults.

Authors:  Lisa A Spacek; Matthew Mudalel; Frank Tittel; Terence H Risby; Steven F Solga
Journal:  J Breath Res       Date:  2015-12-14       Impact factor: 3.262

4.  The microfluidics of the eccrine sweat gland, including biomarker partitioning, transport, and biosensing implications.

Authors:  Z Sonner; E Wilder; J Heikenfeld; G Kasting; F Beyette; D Swaile; F Sherman; J Joyce; J Hagen; N Kelley-Loughnane; R Naik
Journal:  Biomicrofluidics       Date:  2015-05-15       Impact factor: 2.800

5.  Refeeding encephalopathy revisited: Reply to Tasci et al.

Authors:  C L Hvas; S Becker; G Dam
Journal:  Eur J Clin Nutr       Date:  2015-03-18       Impact factor: 4.016

6.  Acid-base disturbances may complicate the diagnosis of refeeding syndrome.

Authors:  I Tasci; M F Bulucu; K Saglam
Journal:  Eur J Clin Nutr       Date:  2015-03-11       Impact factor: 4.016

7.  Fast and accurate exhaled breath ammonia measurement.

Authors:  Steven F Solga; Matthew L Mudalel; Lisa A Spacek; Terence H Risby
Journal:  J Vis Exp       Date:  2014-06-11       Impact factor: 1.355

8.  Glutamate and GABA-metabolizing enzymes in post-mortem cerebellum in Alzheimer's disease: phosphate-activated glutaminase and glutamic acid decarboxylase.

Authors:  G Sh Burbaeva; I S Boksha; E B Tereshkina; O K Savushkina; T A Prokhorova; E A Vorobyeva
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

9.  The effect of pH and ADP on ammonia affinity for human glutamate dehydrogenases.

Authors:  Ioannis Zaganas; Kamilla Pajęcka; Camilla Wendel Nielsen; Arne Schousboe; Helle S Waagepetersen; Andreas Plaitakis
Journal:  Metab Brain Dis       Date:  2013-02-20       Impact factor: 3.584

Review 10.  The metabolomic window into hepatobiliary disease.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  J Hepatol       Date:  2013-05-25       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.